Original ArticleAndrogen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532)
Under an Elsevier user license
open archive
Key words
androgen-deprivation therapy
COVID-19
prostate cancer
Cited by (0)
© 2020 European Society for Medical Oncology. Published by Elsevier Ltd.